SCHEMBL13689529

SCHEMBL13689529

CC(CNC(=O)c1ccc2ccccc2c1)N[C@@H](CCCNC(=N)N)C(=O)N(C)C[C@@H](NC(=O)C1CCCCC1)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITGB3 P05106 2/20 0.37
▸ ITGA2B P08514 2/20 0.37
▸ DRD4 P21917 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ CASP1 P29466 1/20 0.35
▸ OPRM1 P35372 1/20 0.35
▸ TMEM97 Q5BJF2 1/20 0.35
▸ SIGMAR1 Q99720 1/20 0.35
▸ FURIN P09958 1/20 0.35
▸ DRD2 P14416 2/20 0.34
▸ DRD3 P35462 2/20 0.34
▸ GRIN1 Q05586 1/20 0.34
▸ GRIN2A Q12879 1/20 0.34
▸ HDAC3 O15379 1/20 0.34
▸ HDAC4 P56524 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC7 Q8WUI4 1/20 0.34
▸ HDAC2 Q92769 1/20 0.34
▸ HDAC10 Q969S8 1/20 0.34
▸ HDAC11 Q96DB2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13689532 0.98 DRD4 (0.36) ITGB3ITGA2BDRD4NPC1CASP1
SCHEMBL13691803 0.90 ITGB3 (0.38) ITGB3ITGA2BDRD4NPC1OPRM1
SCHEMBL13691796 0.88 OPRM1 (0.38) ITGB3ITGA2BDRD4NPC1OPRM1
SCHEMBL13689393 0.78 OPRM1 (0.42) NPC1OPRM1TMEM97SIGMAR1DRD2
SCHEMBL13689530 0.78 OPRM1 (0.42) NPC1OPRM1TMEM97SIGMAR1DRD2
SCHEMBL13188832 0.77 OPRM1 (0.38) DRD4NPC1OPRM1TMEM97SIGMAR1
SCHEMBL13190965 0.77 CTSL (0.45) FURINGRIN1GRIN2ACTSLCTSS
SCHEMBL13691793 0.74 NPC1 (0.47) DRD4NPC1OPRM1TMEM97SIGMAR1
SCHEMBL13689525 0.73 DRD3 (0.51) DRD4NPC1DRD2DRD3
SCHEMBL13689520 0.73 DRD3 (0.49) DRD4NPC1DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009105824-A1 METHODS OF MODULATING THE ACTIVITY OF THE MC5 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR MIMETICA PTY LTD (AU) 2009-09-03 — — WO disclosed
Send feedback